Phathom Pharmaceuticals shares owned by UBS Group
Quarter-by-quarter ownership of Phathom Pharmaceuticals (PHAT) shares owned by UBS Group
from 13F filings
Historical chart of UBS Group investment in Phathom Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Phathom Pharmaceuticals held by UBS Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Phathom Pharmaceuticals by UBS Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $4.0M | 338k | 11.77 |
| 2025-06-30 | $4.0M | 420k | 9.59 |
| 2025-03-31 | $4.4M | 708k | 6.27 |
| 2024-12-31 | $3.8M | 466k | 8.12 |
| 2024-09-30 | $1.3M | 72k | 18.08 |
| 2024-06-30 | $444k | 43k | 10.30 |
| 2024-03-31 | $530k | 50k | 10.62 |
| 2023-12-31 | $360k | 39k | 9.13 |
| 2023-09-30 | $350k | 34k | 10.37 |
| 2023-06-30 | $241k | 17k | 14.32 |
| 2022-12-31 | $8.9k | 795 | 11.22 |
| 2022-09-30 | $7.0k | 628 | 11.15 |
| 2021-12-31 | $26k | 1.3k | 19.56 |
| 2021-06-30 | $24k | 699 | 34.33 |
| 2021-03-31 | $108k | 2.9k | 37.54 |
| 2020-12-31 | $88k | 2.7k | 33.12 |
| 2020-09-30 | $50k | 1.4k | 36.39 |
| 2020-06-30 | $137k | 4.2k | 32.80 |
| 2020-03-31 | $166k | 6.4k | 25.88 |
| 2019-12-31 | $439k | 14k | 31.14 |